tradingkey.logo

Enovis Corp

ENOV
查看详细走势图
26.840USD
+0.530+2.01%
收盘 12/24, 13:00美东报价延迟15分钟
1.53B总市值
亏损市盈率 TTM

Enovis Corp

26.840
+0.530+2.01%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+2.01%

5天

-1.90%

1月

-9.32%

6月

-16.02%

今年开始到现在

-38.83%

1年

-38.93%

查看详细走势图

TradingKey Enovis Corp股票评分

单位: USD 更新时间: 2025-12-24

操作建议

Enovis Corp当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名43/206位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价48.11。中期看,股价处于下降通道。近一个月,市场表现较差,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Enovis Corp评分

相关信息

行业排名
43 / 206
全市场排名
117 / 4562
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 10 位分析师
买入
评级
48.111
目标均价
+79.79%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Enovis Corp亮点

亮点风险
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
业绩高增长
公司营业收入稳步增长,连续3年增长34.84%
利润高增长
公司净利润处于行业前列,最新年度总收入2.11B美元
估值高估
公司最新PE估值-1.10,处于3年历史高位
CI 精选加拿大股票基金持仓
明星投资者CI 精选加拿大股票基金持仓,最新持仓市值183.00
活跃度降低
近期活跃度降低,过去20天平均换手率0.36

Enovis Corp新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Enovis Corp简介

Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
公司代码ENOV
公司Enovis Corp
CEOMcdonald (Damien)
网址https://www.enovis.com/

常见问题

Enovis Corp(ENOV)的当前股价是多少?

Enovis Corp(ENOV)的当前股价是 26.840。

Enovis Corp的股票代码是什么?

Enovis Corp的股票代码是ENOV。

Enovis Corp股票的52周最高点是多少?

Enovis Corp股票的52周最高点是49.380。

Enovis Corp股票的52周最低点是多少?

Enovis Corp股票的52周最低点是25.465。

Enovis Corp的市值是多少?

Enovis Corp的市值是1.53B。

Enovis Corp的净利润是多少?

Enovis Corp的净利润为-825.49M。

现在Enovis Corp(ENOV)的股票是买入、持有还是卖出?

根据分析师评级,Enovis Corp(ENOV)的总体评级为买入,目标价格为48.111。

Enovis Corp(ENOV)股票的每股收益(EPS TTM)是多少

Enovis Corp(ENOV)股票的每股收益(EPS TTM)是-24.355。
KeyAI